Literature DB >> 21035162

Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition.

Semih U Tareen1, Michael Emerman.   

Abstract

Trim5α is a host antiviral protein that recognizes incoming retroviral capsids in the cytoplasm and prevents productive infections. Although present in most mammals, the state of the Trim5 gene is dynamic in that primates have one copy with several splice variants, while rodents and cows have multiple copies. Mouse Trim30 (one of the mouse Trim5α homologs) has been shown to negatively regulate NF-kappaB activation by targeting upstream signaling intermediates TAB2 and TAB3 for degradation. We show that human Trim5α also affects levels of TAB2, resulting in abrogation of TAB2-dependent NF-kappaB activation. Surprisingly, unlike mouse Trim30, human and rhesus Trim5α are able to activate NF-kappaB-driven reporter gene expression in a dose-dependent manner. We show that Trim5α uses distinct domains for the distinct abilities of affecting TAB2 levels, regulating NF-kappaB, and recognizing retroviral capsids. Our results demonstrate functions of Trim5α that are not dependent on recognizing the retroviral capsid.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035162      PMCID: PMC3051842          DOI: 10.1016/j.virol.2010.09.018

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

1.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.

Authors:  Jenny L Anderson; Edward M Campbell; Xiaolu Wu; Nick Vandegraaff; Alan Engelman; Thomas J Hope
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Adaptive evolution of primate TRIM5alpha, a gene restricting HIV-1 infection.

Authors:  Hong-Liang Liu; Yin-Qiu Wang; Cheng-Hong Liao; Yi-Qun Kuang; Yong-Tang Zheng; Bing Su
Journal:  Gene       Date:  2005-10-13       Impact factor: 3.688

4.  TRIM-ing down Tolls.

Authors:  Andrew G Bowie
Journal:  Nat Immunol       Date:  2008-04       Impact factor: 25.606

5.  p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha.

Authors:  Christopher O'Connor; Thomas Pertel; Seth Gray; Seth L Robia; Joanna C Bakowska; Jeremy Luban; Edward M Campbell
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

6.  TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.

Authors:  Jae-Hyuck Shim; Changchun Xiao; Amber E Paschal; Shannon T Bailey; Ping Rao; Matthew S Hayden; Ki-Young Lee; Crystal Bussey; Michael Steckel; Nobuyuki Tanaka; Gen Yamada; Shizuo Akira; Kunihiro Matsumoto; Sankar Ghosh
Journal:  Genes Dev       Date:  2005-10-31       Impact factor: 11.361

Review 7.  The role of ubiquitin in NF-kappaB regulatory pathways.

Authors:  Brian Skaug; Xiaomo Jiang; Zhijian J Chen
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

8.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

Review 9.  The HTLV-1 Tax interactome.

Authors:  Mathieu Boxus; Jean-Claude Twizere; Sébastien Legros; Jean-François Dewulf; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2008-08-14       Impact factor: 4.602

10.  Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals.

Authors:  Sara L Sawyer; Michael Emerman; Harmit S Malik
Journal:  PLoS Pathog       Date:  2007-12       Impact factor: 6.823

View more
  46 in total

1.  TRIM5α-Mediated Ubiquitin Chain Conjugation Is Required for Inhibition of HIV-1 Reverse Transcription and Capsid Destabilization.

Authors:  Edward M Campbell; Jared Weingart; Paola Sette; Silvana Opp; Jaya Sastri; Sarah K O'Connor; Sarah Talley; Felipe Diaz-Griffero; Vanessa Hirsch; Fadila Bouamr
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

2.  K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.

Authors:  Sabrina Imam; Sevnur Kömürlü; Jessica Mattick; Anastasia Selyutina; Sarah Talley; Amani Eddins; Felipe Diaz-Griffero; Edward M Campbell
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

3.  Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease?

Authors:  Caroline Jefferies; Claire Wynne; Rowan Higgs
Journal:  Nat Rev Immunol       Date:  2011-08-25       Impact factor: 53.106

4.  TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity.

Authors:  Pradeep D Uchil; Angelika Hinz; Steven Siegel; Anna Coenen-Stass; Thomas Pertel; Jeremy Luban; Walther Mothes
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

5.  Trim5 TAKes on pattern recognition.

Authors:  Semih U Tareen; Michael Emerman
Journal:  Cell Host Microbe       Date:  2011-05-19       Impact factor: 21.023

6.  Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Authors:  Antonella Sistigu; Takahiro Yamazaki; Erika Vacchelli; Kariman Chaba; David P Enot; Julien Adam; Ilio Vitale; Aicha Goubar; Elisa E Baracco; Catarina Remédios; Laetitia Fend; Dalil Hannani; Laetitia Aymeric; Yuting Ma; Mireia Niso-Santano; Oliver Kepp; Joachim L Schultze; Thomas Tüting; Filippo Belardelli; Laura Bracci; Valentina La Sorsa; Giovanna Ziccheddu; Paola Sestili; Francesca Urbani; Mauro Delorenzi; Magali Lacroix-Triki; Virginie Quidville; Rosa Conforti; Jean-Philippe Spano; Lajos Pusztai; Vichnou Poirier-Colame; Suzette Delaloge; Frederique Penault-Llorca; Sylvain Ladoire; Laurent Arnould; Joanna Cyrta; Marie-Charlotte Dessoliers; Alexander Eggermont; Marco E Bianchi; Mikael Pittet; Camilla Engblom; Christina Pfirschke; Xavier Préville; Gilles Uzè; Robert D Schreiber; Melvyn T Chow; Mark J Smyth; Enrico Proietti; Fabrice André; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2014-10-26       Impact factor: 53.440

7.  Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.

Authors:  Paulina Pawlica; Valerie Le Sage; Nolwenn Poccardi; Michel J Tremblay; Andrew J Mouland; Lionel Berthoux
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

8.  The cytoplasmic domain of the HIV-1 glycoprotein gp41 induces NF-κB activation through TGF-β-activated kinase 1.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  Cell Host Microbe       Date:  2012-02-16       Impact factor: 21.023

Review 9.  The innate immune roles of host factors TRIM5α and Cyclophilin A on HIV-1 replication.

Authors:  Yi-Qun Kuang; Hong-Liang Liu; Yong-Tang Zheng
Journal:  Med Microbiol Immunol       Date:  2015-04-19       Impact factor: 3.402

10.  Dynamic conformational changes in the rhesus TRIM5α dimer dictate the potency of HIV-1 restriction.

Authors:  Rajan Lamichhane; Santanu Mukherjee; Nikolai Smolin; Raymond F Pauszek; Margret Bradley; Jaya Sastri; Seth L Robia; David Millar; Edward M Campbell
Journal:  Virology       Date:  2016-11-04       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.